One in 10 Mental Health-Related ED Visits Among Youths Involve Boarding
By Lori Solomon HealthDay Reporter

WEDNESDAY, Aug. 20, 2025 -- Boarding is a considerable issue for Medicaid-enrolled youths seeking mental health care in emergency departments (EDs), according to a research letter published online Aug. 15 in JAMA Health Forum.
K. John McConnell, Ph.D., from the Oregon Health & Science University in Portland, and colleagues investigated the prevalence of and variations in boarding (spanning two to six midnights) for ED visits for mental health conditions among Medicaid-enrolled youths (aged 5 to 17 years) in 2022. The analysis included 255,139 ED visits for mental health conditions.
The researchers found that more than one in 10 ED visits (11.9 percent) resulted in three to seven days of boarding (mean, 4.5 days). Among individuals with primary diagnoses of suicide-related behaviors and depressive disorders, boarding was prevalent. There was substantial variation in boarding rates across states, with those in the bottom quintile having rates below 7.6 percent and those in the highest quintile above 15.4 percent. The lowest rate of mental health ED visits resulting in a boarding event was seen in Arkansas (2.7 percent), while Iowa had the highest (27.3 percent). Boarding occurred in more than one in five visits in Montana, North Carolina, Maine, Florida, and Iowa (21.8 to 27.3 percent).
"Boarding poses a substantial emotional toll on patients, families, and staff; it also may result in challenges related to patient and staff safety and restraint use, and it suggests an inability to find timely and appropriate care for youths in crisis," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-21 06:00
Read more

- Leukemia & Lymphoma Society Changing Name to Blood Cancer United
- Remote CBT-Based Therapy Yields Modest Improvements in Chronic Pain
- Risk of Long COVID Greater for Individuals With Social Risk Factors
- Irritable Bowel Syndrome Still Routinely Disrupts Patients' Lives
- Could a Single Shot at Birth Shield Kids From HIV for Years?
- Federal Judge Halts Plan to Defund Planned Parenthood Through Medicaid
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions